NASDAQ:KTTA

Pasithea Therapeutics Stock Forecast

etoro logo Buy KTTA
*Your capital is at risk
$0.450
-0.0072 (-1.57%)
At Close: Jul 17, 2026
AI Analysis AI Analysis of KTTA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add KTTA to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Pasithea Therapeutics Corp. stock downgraded to Strong Sell Candidate
(Updated on Jul 17, 2026)

Sell candidate since Jul 02, 2026 Loss -18.15%

The Pasithea Therapeutics Corp. stock price fell by -1.57% on the last day (Friday, 17th Jul 2026) from $0.457 to $0.450. It has now fallen 10 days in a row. During the last trading day the stock fluctuated 2.58% from a day low at $0.445 to a day high of $0.457. The price has fallen in 10 of the last 10 days and is down by -18.15% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -98 thousand shares and in total, 196 thousand shares were bought and sold for approximately $87.99 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -37.22% during the next 3 months and, with a 90% probability hold a price between $0.248 and $0.359 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

KTTA Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Pasithea Therapeutics Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.479 and $0.555. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 23, 2026, and so far it has fallen -20.77%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Pasithea Therapeutics Corp. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0115 between high and low, or 2.58%. For the last week the stock has had daily average volatility of 6.99%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KTTA) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Pasithea Therapeutics Corp. to open at $0.451, and during the day (based on 14 day Average True Range), to move between $0.427 and $0.473, which gives a possible trading interval of +/-$0.0467 (+/-10.94%) up or down from last closing price. If Pasithea Therapeutics Corp. takes out the full calculated possible swing range there will be an estimated 10.94% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.510, some $0.0600 (13.33%) from the current price of $0.450, our system finds the risk reward not very attractive.

Is Pasithea Therapeutics Corp. stock A Buy?

Pasithea Therapeutics Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.776 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $0.451 ( 0.141%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

KTTA Performance

Trading levels for KTTA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.462 2.70%
R2 0.458 1.72%
R1 0.455 1.12%
Price 0.450
S1 0.446 -0.84%
S2 0.444 -1.44%
S3 0.439 -2.41%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.539 19.76%
R2 0.515 14.53%
R1 0.510 13.33%
Price 0.450
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Pasithea Therapeutics Corp. Stock and on which exchange is it traded?
The symbol for Pasithea Therapeutics Corp. is KTTA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pasithea Therapeutics Corp. Stock?
Pasithea Therapeutics Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Pasithea Therapeutics Corp. Stock?
Pasithea Therapeutics Corp. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pasithea Therapeutics Corp. Stock.

What's the current price of Pasithea Therapeutics Corp. Stock?
As of the end of day on the Jul 17, 2026, the price of an Pasithea Therapeutics Corp. (KTTA) share was $0.450.

What is the 52-week high and low for Pasithea Therapeutics Corp. Stock?
The 52-week high for Pasithea Therapeutics Corp. Stock is $2.06 and the 52-week low is $0.281.

What is the market capitalization of Pasithea Therapeutics Corp. Stock?
As of the Jul 17, 2026, the market capitalization of Pasithea Therapeutics Corp. is 3.403M.

When is the next earnings date for Pasithea Therapeutics Corp.?
The upcoming earnings date for Pasithea Therapeutics Corp. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT PASITHEA THERAPEUTICS CORP.
Pasithea Therapeutics
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida....
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE